Daniel P Van Plew is EVP & General Mgr, Industrial of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 20,378 shares of REGN, which is worth approximately $23.5 Million. The most recent transaction as insider was on Feb 14, 2024, when has been sold 10,434 shares (Common Stock) at a price of $944.53 per share, resulting in proceeds of $9,855,226. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.4K
0% 3M change
5.25% 12M change
Total Value Held $23.5 Million

Daniel P Van Plew Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2024
SELL
Open market or private sale
$9,855,226 $944.53 p/Share
10,434 Reduced 33.86%
20,378 Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$23,735,850 $951.68 p/Share
24,941 Reduced 44.73%
30,812 Common Stock
Feb 09 2024
BUY
Exercise of conversion of derivative security
$13,333,898 $376.93 p/Share
35,375 Added 42.86%
47,153 Common Stock
Dec 11 2023
SELL
Payment of exercise price or tax liability
$2,718,813 $844.09 p/Share
3,221 Reduced 13.65%
20,378 Common Stock
Dec 08 2023
SELL
Payment of exercise price or tax liability
$934,919 $843.79 p/Share
1,108 Reduced 5.15%
20,400 Common Stock
Dec 08 2023
BUY
Grant, award, or other acquisition
-
3,199 Added 11.94%
23,599 Common Stock
Aug 24 2023
SELL
Open market or private sale
$5,205,046 $839.93 p/Share
6,197 Reduced 22.37%
21,508 Common Stock
Aug 23 2023
SELL
Payment of exercise price or tax liability
$14,264,548 $842.66 p/Share
16,928 Reduced 37.93%
27,705 Common Stock
Aug 23 2023
BUY
Exercise of conversion of derivative security
$8,819,875 $381.4 p/Share
23,125 Added 34.13%
44,633 Common Stock
Dec 16 2022
BUY
Grant, award, or other acquisition
-
3,798 Added 10.08%
33,884 Common Stock
Dec 09 2022
SELL
Payment of exercise price or tax liability
$370,613 $753.28 p/Share
492 Reduced 1.61%
30,086 Common Stock
Nov 23 2022
SELL
Open market or private sale
$8,882,625 $741.95 p/Share
11,972 Reduced 28.14%
30,578 Common Stock
Nov 22 2022
SELL
Payment of exercise price or tax liability
$28,209,550 $741.81 p/Share
38,028 Reduced 47.19%
42,550 Common Stock
Nov 22 2022
BUY
Exercise of conversion of derivative security
$18,949,000 $378.98 p/Share
50,000 Added 38.29%
80,578 Common Stock
Nov 07 2022
SELL
Open market or private sale
$5,875,148 $745.01 p/Share
7,886 Reduced 20.5%
30,578 Common Stock
Nov 04 2022
SELL
Payment of exercise price or tax liability
$18,954,585 $725.84 p/Share
26,114 Reduced 40.44%
38,464 Common Stock
Nov 04 2022
BUY
Exercise of conversion of derivative security
$12,985,280 $381.92 p/Share
34,000 Added 34.49%
64,578 Common Stock
Sep 12 2022
SELL
Open market or private sale
$3,362,571 $716.05 p/Share
4,696 Reduced 13.31%
30,578 Common Stock
Sep 09 2022
SELL
Payment of exercise price or tax liability
$25,805,813 $730.96 p/Share
35,304 Reduced 50.02%
35,274 Common Stock
Sep 09 2022
BUY
Exercise of conversion of derivative security
$22,226,799 $555.67 p/Share
40,000 Added 36.17%
70,578 Common Stock
Feb 23 2022
SELL
Open market or private sale
$4,156,210 $612.92 p/Share
6,781 Reduced 18.15%
30,578 Common Stock
Feb 22 2022
SELL
Payment of exercise price or tax liability
$20,282,193 $610.56 p/Share
33,219 Reduced 47.07%
37,359 Common Stock
Feb 22 2022
BUY
Exercise of conversion of derivative security
$15,986,400 $399.66 p/Share
40,000 Added 36.17%
70,578 Common Stock
Dec 11 2021
SELL
Payment of exercise price or tax liability
$463,045 $664.34 p/Share
697 Reduced 2.23%
30,578 Common Stock
Dec 08 2021
BUY
Grant, award, or other acquisition
-
4,344 Added 12.2%
31,275 Common Stock
DPV

Daniel P Van Plew

EVP & General Mgr, Industrial
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN